Curious about PrEP? There’s a Website Just for You
For people at high risk for HIV infection, pre-exposure prophylaxis (PrEP) offers a new way to stay HIV negative—and the new website PrEPfacts.org can help you understand and make the most of this groundbreaking HIV prevention tool.
Based on studies showing that a daily dose of the antiretroviral drug Truvada reduced HIV risk by up to 92%, last July the U.S. Food and Drug Administration approved the drug for use by HIV-negative people to prevent infection. (For an in-depth look at PrEP science, read Liz Highleyman’s excellent BETA article, “Prepare for PrEP.”)
Want to know how PrEP works, why taking it daily is key to avoiding infection, and what researchers, care providers, and community advocates are doing to maximize this new prevention tool? Check out PrEPfacts.org, a user-friendly source of news and reliable information on PrEP and the demonstration projects planned in U.S. cities. The website is a collaborative project of San Francisco AIDS Foundation, San Francisco Department of Public Health, the National Institute of Allergy and Infectious Diseases, Project Inform, and other community partners and PrEP supporters.
Whether you’re just learning about pre-exposure prophylaxis for the first time, are interested in being part of a study, or want to know how to ask your medical provider about starting PrEP, the site has something for you.
See for yourself! Visit PrEPfacts.org and learn all about this game-changing way to prevent HIV.
Reilly O’Neal is a freelance writer and former editor of BETA.